Stockscreener 앱 받기
3.875
1.71%
0.065
Cytomx Therapeutics Inc 주식(CTMX)의 최신 뉴스
CytomX Therapeutics outlines its oncology focus as investors watch Nasdaq trading - AD HOC NEWS
CTMX Stock Garners Price Target Revisions After Colorectal Cancer Trial Data: Jefferies Sees As Much As 230% Upside - Stocktwits
CTMX Stock Pulls Back After 5-Year High: Share Sale Sparks Dilution Fears Despite Wall Street’s 150% Upside Calls - Stocktwits
CytomX Therapeutics, Inc.(NasdaqGS:CTMX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS: CTMX) added to Russell 2000 Index - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS: CTMX) added to Russell 2000 Value Benchmark - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS:CTMX) added to Russell Microcap Value Benchmark Index - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS: CTMX) added to Russell 3000E Index - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS: CTMX) added to Russell Microcap Index - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS: CTMX) added to Russell 3000E Growth Benchmark - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS: CTMX) added to Russell 3000 Index - marketscreener.com
CytomX Therapeutics, Inc.(NasdaqGS:CTMX) added to Russell Small Cap Completeness Index - marketscreener.com
Price to book forward of CytomX Therapeutics, Inc. – NASDAQ:CTMX - TradingView
Enterprise value to EBIT forward of CytomX Therapeutics, Inc. – NASDAQ:CTMX - TradingView
Price to sales forward of CytomX Therapeutics, Inc. – NASDAQ:CTMX - TradingView
Enterprise value to revenue forward of CytomX Therapeutics, Inc. – NASDAQ:CTMX - TradingView
CytomX Therapeutics, Inc. Actuals & Estimates (NASDAQ:CTMX) - TradingView
CTMX Forecast — Price Target — Prediction for 2027 - TradingView
CytomX Shareholders Approve Expanded Equity and Capital Plans - The Globe and Mail
Form 4 CytomX Therapeutics Inc For: 22 June By Investing.com - Investing.com India
CytomX Therapeutics Amends Equity Incentive and Employee Stock Purchase Plans Following 2026 Shareholder Approval – Minichart - Minichart
CytomX Therapeutics stockholders approve share increases and board elections - Investing.com
CytomX Therapeutics stockholders approve share increases and board elections By Investing.com - Investing.com Canada
Form 8K CytomX Therapeutics Inc For: 22 June By Investing.com - Investing.com South Africa
CytomX (CTMX) director Su Zhen awarded 59,000 stock options at $2.96 - Stock Titan
[8-K] CytomX Therapeutics, Inc. Reports Material Event - Stock Titan
Director at CytomX (NASDAQ: CTMX) awarded 59,000 stock options - Stock Titan
Director at CytomX (NASDAQ: CTMX) receives 59,000-stock option award - Stock Titan
CytomX (CTMX) director receives 59,000 stock options at $2.96 - Stock Titan
CytomX (CTMX) director Halley Gilbert receives 59,000 stock options at $2.96 strike - Stock Titan
CytomX (CTMX) director Alan Ashworth receives grant of 59,000 stock options - Stock Titan
CytomX (CTMX) director Elaine Jones awarded 59,000 stock options at $2.96 strike - Stock Titan
Is CytomX (CTMX) One of the Best Growth Stocks Under $30 to Buy Now? - Insider Monkey
CytomX Therapeutics Inc (CTMX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CytomX CFO Ogden sells $4,953 in company stock By Investing.com - Investing.com South Africa
CytomX CFO Ogden sells $4,953 in company stock - Investing.com
CytomX Therapeutics (CTMX) CFO sells shares to cover RSU tax withholding - Stock Titan
10 Best Growth Stocks Under $30 to Buy Now - Insider Monkey
CytomX Therapeutics Inc (CTMX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CytomX Therapeutics Inc (CTMX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CytomX Therapeutics Inc (CTMX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CytomX Therapeutics Inc (CTMX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CytomX Therapeutics Inc (CTMX) Valuation: PE, PB & Fair Value Analysis - TradingKey
CytomX Therapeutics Inc (CTMX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CytomX Therapeutics Inc (CTMX) Institutional Confidence - TradingKey
CytomX Therapeutics Inc (CTMX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
How The Narrative Around CytomX Therapeutics (CTMX) Is Evolving With Recent Developments - Yahoo Finance
Transcript : CytomX Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 09 - marketscreener.com
CytomX Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
1.98%
3.59%
자본화:
|
볼륨(24시간):